Tyra Biosciences, Inc. Shares Outstanding (Cover Page)
Tyra Biosciences, Inc. (TYRA) had Shares Outstanding (Cover Page) of 59.68 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 59.68M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 59.47M shares.
- 2026-02-25: Entity Common Stock, Shares Outstanding 53.87M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 53.37M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 59.68M shares 10-Q · filed 2026-08-04 |
| 2026-05-08 | 59.47M shares 10-Q · filed 2026-05-13 |
| 2026-02-25 | 53.87M shares 10-K · filed 2026-03-02 |
| 2025-10-31 | 53.37M shares 10-Q · filed 2025-11-05 |
| 2025-08-11 | 53.30M shares 10-Q · filed 2025-08-14 |
| 2025-05-05 | 53.18M shares 10-Q · filed 2025-05-08 |
| 2025-03-25 | 53.09M shares 10-K · filed 2025-03-27 |
| 2024-11-04 | 50.60M shares 10-Q · filed 2024-11-07 |
| 2024-08-05 | 52.81M shares 10-Q · filed 2024-08-07 |
| 2024-05-08 | 52.54M shares 10-Q · filed 2024-05-09 |
| 2024-03-15 | 52.52M shares 10-K · filed 2024-03-19 |
| 2023-11-06 | 43.06M shares 10-Q · filed 2023-11-07 |
| 2023-08-07 | 43.01M shares 10-Q · filed 2023-08-10 |
| 2023-05-02 | 42.56M shares 10-Q · filed 2023-05-04 |
| 2023-03-20 | 42.44M shares 10-K · filed 2023-03-22 |
| 2022-10-31 | 42.20M shares 10-Q · filed 2022-11-03 |
| 2022-07-31 | 41.97M shares 10-Q · filed 2022-08-04 |
| 2022-04-30 | 41.76M shares 10-Q · filed 2022-05-05 |
| 2022-02-28 | 41.60M shares 10-K · filed 2022-03-03 |
| 2021-10-31 | 41.27M shares 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |